Search Results - "Alvo, Fernando Salgueiro"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Safety of human papillomavirus 6, 11, 16 and 18 (recombinant): systematic review and meta-analysis by Coelho, Pedro Luiz Spinelli, Calestini, Gustavo Lacerda da Silva, Alvo, Fernando Salgueiro, Freitas, Jefferson Michel de Moura, Castro, Paula Marcela Vilela, Konstantyner, Tulio

    Published in Revista Paulista de Pediatria (01-12-2015)
    “…Objective: To identify and quantify the adverse effects associated with the recombinant human papillomavirus (types 6, 11, 16 and 18) vaccine in adolescents…”
    Get full text
    Journal Article
  2. 2

    Müller-Weiss disease: a functional and quality of life assessment by Molina, Wellington Farias, Nogueira, Monica Paschoal, Alvo, Fernando Salgueiro, Heitzmann, Lourenço Galizia

    Published in International orthopaedics (01-08-2023)
    “…Purpose Evaluate the functional health status and quality of life of patients diagnosed with Müller-Weiss disease and, secondarily, determine the influence of…”
    Get full text
    Journal Article
  3. 3

    Safety of human papillomavirus 6, 11, 16 and 18 (recombinant): systematic review and meta-analysis by Coelho, Pedro Luiz Spinelli, da Silva Calestini, Gustavo Lacerda, Alvo, Fernando Salgueiro, de Moura Freitas, Jefferson Michel, Castro, Paula Marcela Vilela, Konstantyner, Tulio

    Published in Revista paulista de pediatria (01-12-2015)
    “…To identify and quantify the adverse effects associated with the recombinant human papillomavirus (types 6, 11, 16 and 18) vaccine in adolescents. Systematic…”
    Get full text
    Journal Article
  4. 4

    Segurança da vacina papillomavirus humano 6, 11, 16 e 18 (recombinante): revisão sistemática e metanálise by Coelho, Pedro Luiz Spinelli, Calestini, Gustavo Lacerda da Silva, Alvo, Fernando Salgueiro, Freitas, Jefferson Michel de Moura, Castro, Paula Marcela Vilela, Konstantyner, Tulio

    Published in Revista paulista de pediatria (01-12-2015)
    “…Identificar e quantificar os efeitos adversos associados à vacina papillomavirus humano 6, 11, 16 e 18 (recombinante) em adolescentes. Revisão sistemática de…”
    Get full text
    Journal Article
  5. 5